Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fate Therapeutics (FATE) Amortization of Deferred Charges (2016 - 2023)

Fate Therapeutics' Amortization of Deferred Charges history spans 12 years, with the latest figure at $7.2 million for Q1 2023.

  • For Q1 2023, Amortization of Deferred Charges rose 557.77% year-over-year to $7.2 million; the TTM value through Dec 2023 reached $7.2 million, up 168.91%, while the annual FY2023 figure was $7.2 million, 168.91% up from the prior year.
  • Amortization of Deferred Charges reached $7.2 million in Q1 2023 per FATE's latest filing, up from $1.1 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $7.2 million in Q1 2023 to a low of -$331000.0 in Q2 2022.
  • Average Amortization of Deferred Charges over 5 years is $1.0 million, with a median of $623000.0 recorded in 2021.
  • Peak YoY movement for Amortization of Deferred Charges: skyrocketed 1966.67% in 2020, then tumbled 133.81% in 2022.
  • A 5-year view of Amortization of Deferred Charges shows it stood at -$123000.0 in 2019, then surged by 1604.07% to $1.8 million in 2020, then crashed by 30.43% to $1.3 million in 2021, then decreased by 12.2% to $1.1 million in 2022, then skyrocketed by 536.81% to $7.2 million in 2023.
  • Per Business Quant, the three most recent readings for FATE's Amortization of Deferred Charges are $7.2 million (Q1 2023), $1.1 million (Q4 2022), and $783000.0 (Q3 2022).